Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China · Delayed Price · Currency is CNY 17.10
+0.10 (0.59%)
At close: Dec 5, 2025
SHA:600161 Market Cap
SHA:600161 has a market cap or net worth of 33.81 billion as of December 5, 2025. Its market cap has decreased by -24.54% in one year.
Market Cap
33.81B
Enterprise Value
35.63B
Revenue
6.42B
Ranking
n/a
PE Ratio
25.93
Stock Price
17.10
Market Cap Chart
Since March 8, 2000, SHA:600161's market cap has increased from 3.95B to 33.81B, an increase of 756.56%. That is a compound annual growth rate of 8.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 33.81B | -16.59% |
| Dec 31, 2024 | 40.54B | -20.49% |
| Dec 29, 2023 | 50.98B | 30.38% |
| Dec 30, 2022 | 39.10B | -1.67% |
| Dec 31, 2021 | 39.77B | -23.98% |
| Dec 31, 2020 | 52.31B | 79.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 407.03B |
| WuXi AppTec | 267.43B |
| Shenzhen Mindray Bio-Medical Electronics | 241.88B |
| Sichuan Biokin Pharmaceutical | 150.71B |
| Shanghai United Imaging Healthcare | 105.68B |
| Aier Eye Hospital Group | 105.04B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.81B |
| Yunnan Baiyao Group Co.,Ltd | 99.44B |